Paper38003261
Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.
Jinna N and 2 others. Int J Mol Sci, 2023. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers. Papers, record 38003261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38003261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Female | |
| Humans | |
| Family | |
| Kaplan-Meier Estimate | |
| Kinesins | |
| Receptors, Androgen |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA033572 | NCI NIH HHS | United States | P30CA033572 | PubMed | NIH RePORTER |
| T32 CA221709 | NCI NIH HHS | United States | T32CA221709 | PubMed and NIH | NIH RePORTER |
| U01 CA189283 | NCI NIH HHS | United States | U01CA189283 | PubMed | NIH RePORTER |
| T32CA221709 | NIH HHS | United States | T32CA221709 | PubMed and NIH | NIH RePORTER |
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30570854 | Association between androgen receptor status and prognosis in triple negative breast cancer. | J BUON | 2018 | https://conductscience.org/library/papers/30570854 | PubMed |
| 2 | 33393851 | Compression Pressure Variability in Upper Limb Multilayer Bandaging Applied by Lymphedema Therapists. | Lymphat Res Biol | 2021 | https://conductscience.org/library/papers/33393851 | PubMed |
| 3 | 21519872 | The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. | Med Oncol | 2012 | https://conductscience.org/library/papers/21519872 | PubMed |
| 4 | 29912871 | AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature. | PLoS One | 2018 | https://conductscience.org/library/papers/29912871 | PubMed |
| 5 | 37182247 | The relationship between the degree of subcutaneous fluid accumulation and the lymphatic diameter. | J Plast Reconstr Aesthet Surg | 2023 | https://conductscience.org/library/papers/37182247 | PubMed |
| 6 | 29883487 | Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features. | PLoS One | 2018 | https://conductscience.org/library/papers/29883487 | PubMed |
| 7 | 35143040 | Cancer statistics for African American/Black People 2022. | CA Cancer J Clin | 2022 | https://conductscience.org/library/papers/35143040 | PubMed |
| 8 | 17146782 | Prognostic markers in triple-negative breast cancer. | Cancer | 2007 | https://conductscience.org/library/papers/17146782 | PubMed |
| 9 | 33328560 | The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma. | Sci Rep | 2020 | https://conductscience.org/library/papers/33328560 | PubMed |
| 10 | 24505496 | Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options. | PLoS One | 2014 | https://conductscience.org/library/papers/24505496 | PubMed |
| 11 | 25788277 | HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients. | Oncotarget | 2015 | https://conductscience.org/library/papers/25788277 | PubMed |
| 12 | 26752609 | Magnetic resonance lymphangiography: How to prove it? | J Magn Reson Imaging | 2016 | https://conductscience.org/library/papers/26752609 | PubMed |
| 13 | 26177331 | KIFC1 is a novel potential therapeutic target for breast cancer. | Cancer Biol Ther | 2015 | https://conductscience.org/library/papers/26177331 | PubMed |
| 14 | 22946058 | Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET. | J Cell Sci | 2012 | https://conductscience.org/library/papers/22946058 | PubMed |
| 15 | 31577729 | Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis. | Medicine (Baltimore) | 2019 | https://conductscience.org/library/papers/31577729 | PubMed |
| 16 | 31427547 | Androgen receptor expression in triple negative breast carcinoma and its association with the clinicopathological parameters. | Malays J Pathol | 2019 | https://conductscience.org/library/papers/31427547 | PubMed |
| 17 | 27058032 | Role of the androgen receptor in triple-negative breast cancer. | Clin Adv Hematol Oncol | 2016 | https://conductscience.org/library/papers/27058032 | PubMed |
| 18 | 21264529 | Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray. | Med Oncol | 2012 | https://conductscience.org/library/papers/21264529 | PubMed |
| 19 | 36139643 | Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36139643 | PubMed |
| 20 | 36405944 | Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria. | Ecancermedicalscience | 2022 | https://conductscience.org/library/papers/36405944 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42611083 | Integrated bulk, single-cell and spatial transcriptomic analyses identify KIFC1 as a driver of malignant progression in lung adenocarcinoma. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42611083 | PubMed |
| 42279376 | Racial Disparity in Ductal Carcinoma in Situ: Risk-Predictive and Actionable Biomarkers for Early Intervention. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279376 | PubMed |
| 40897935 | Advances of androgen receptor in triple-negative breast cancer: from molecular mechanisms to clinical applications. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40897935 | PubMed |
| 40878344 | Prognostic significance of the kinesin superfamily in breast cancer: A systematic review & meta-analysis. | Indian J Med Res | 2025 | https://conductscience.org/library/papers/40878344 | PubMed |
| 40857057 | KIFC1 Overexpression Promotes Pancreatic Carcinoma Progression via Stabilising BUB1B. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40857057 | PubMed |
| 40440343 | Two cancer cell lines utilize Myosin 10 and the kinesin HSET differentially to maintain mitotic spindle bipolarity. | PLoS One | 2025 | https://conductscience.org/library/papers/40440343 | PubMed |
| 39387242 | Targeting KIFC1 Promotes Senescence in Soft Tissue Sarcoma via FXR1-Dependent Regulation of MAD2L1 mRNA Stability. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39387242 | PubMed |
| 39335162 | FOXM1 Transcriptionally Co-Upregulates Centrosome Amplification and Clustering Genes and Is a Biomarker for Poor Prognosis in Androgen Receptor-Low Triple-Negative Breast Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39335162 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38003261
GET https://conductscience.org/api/papers/v1/38003261/references?page=2